Notes
Slide Show
Outline
1
 
2
Who is Luminex?
  • Luminex develops and manufactures xMAP® Technology – Multiplex liquid bead arrays
3
Peer-reviewed publications
  • 1,915 total peer-reviewed papers using Luminex technology


  • 562 on pharmaceutical/therapeutic development
    • 55 papers in this area in 2008, to date
    • 21% of a total of 268 papers so far in 2008
4
2008 Selected publications
  • Fraccarollo, D., P. Galuppo, et al. (2008). "Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response." Hypertension: HYPERTENSIONAHA.107.100941.


  • Hegde, V. L., S. Hegde, et al. (2008). "Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory T cells." Mol. Pharmacol.: mol.108.047035.


  • Huber, L. C., P. Kunzler, et al. (2008). "Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts." Ann Rheum Dis 67(3): 389-394.


  • Jiz, M., H.-W. Wu, et al. (2008). "Pilot Scale Production and Characterization of Paramyosin, a Vaccine Candidate for Schistosomiasis japonica." Infect. Immun.: IAI.00409-08.


  • Mogensen, T. H., R. S. Berg, et al. (2008). "Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria meningitidis and Streptococcus pneumoniae." Infect. Immun. 76(1): 189-197.


  • Oh, Y., R. S. Herbst, et al. (2008). "Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non-Small-Cell Lung Cancer." J. Clin. Oncol. 26(7): 1135-1141.


  • Rezzoug, F., Y. Huang, et al. (2008). "TNF-{alpha} Is Critical to Facilitate Hemopoietic Stem Cell Engraftment and Function." J. Immunol. 180(1): 49-57.


  • Richardson, M. A., A. Gupta, et al. (2008). "Treatment of Sepsis-Induced Acquired Protein C Deficiency Reverses ACE-2 Inhibition and Decreases Pulmonary Inflammatory Response." J. Pharmacol. Exp. Ther.: jpet.107.130609.


  • Wardenburg, J. B. and O. Schneewind (2008). "Vaccine protection against Staphylococcus aureus pneumonia." J. Exp. Med.: jem.20072208.


  • Zhong, H., B. Han, et al. (2007). "Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth." Clin. Cancer Res. 13(18): 5455-5462.
5
Unpublished research (AACR 2008)
  • Demonstration of Gardasil specificity by multiplex bead-based assay
    • Merck
    • Multiple virus-like particles conjugated to beads
    • Specificity of Gardasil in serum tested against multiple VLPs



  • Cell-based and cytokine-directed chemical screen predicts the drug potency with anti-multiple myeloma activities
    • U of Pittsburgh
    • Cytokine profile associated with malignant transformation known
    • Drug library screened for potency in reducing expression of this profile
      • Rational drug discovery method
6
Technology Background
  • Technology platform basics
    • Industry advances in multiplex and parallel analysis
7
How Does xMAP® Technology Work?
  • 5.6 micron microspheres


8
How Does xMAP® Technology Work?
  • 5.6 micron microspheres
  • Proprietary dyes and dyeing process


9
How Does xMAP® Technology Work?
  • 5.6 micron microspheres
  • Proprietary dyes and dyeing process
  • Spectrally distinct microsphere sets


10
How Does xMAP® Technology Work?
  • 5.6 micron microspheres
  • Proprietary dyes and dyeing process
  • Spectrally distinct microsphere sets
  • Assay chemistry on bead surface


11
How Does xMAP® Technology Work?
  • Assays are read using a compact microsphere analyzer
12
How Does xMAP® Technology Work?
  • Assays are read using a compact microsphere analyzer
  • Analyzer samples well
13
How Does xMAP® Technology Work?
  • Assays are read using a compact microsphere analyzer
  • Analyzer samples well
  • Lasers excite fluorescent dyes
    • Red laser for bead classification
    • Green laser for assay result
14
How Does xMAP® Technology Work?
  • Assays are read using a compact microsphere analyzer
  • Analyzer samples well
  • Lasers excite fluorescent dyes
    • Red laser for bead classification
    • Green laser for assay result
  • Multiple readings for each microsphere set
15
Applications
16
Summary
  • Versatility
    • A single xMAP technology-based system can perform bioassays in several different formats
      • Nucleic acids
      • Antigen-antibody binding
      • Enzyme assays
      • Receptor-ligand
  • Open architecture system
    • Available kits and systems
    • “Home brew” assays
  • Accuracy and reproducibility
    • High-volume production of xMAP microspheres within a single lot allows assay standardization that solid-phased flat arrays cannot provide
  • Speed/throughput
    • Each microsphere is an individual test: a large number of different bioassays can be performed and analyzed simultaneously
  • Focused, flexible multiplexing
17
Thank you
  • More information at www.luminexcorp.com